Molina Healthcare(MOH)
$209.25+2.90 (+1.41%)
MOH
Molina Healthcare financials statements
$209.25
At close:+2.90 (+1.41%)
Want to see MOH full AI Analyst Report?
Molina Healthcare (MOH) Ratios
1,204 Followers
Molina Healthcare Ratios
MOH's free cash flow for Q3 2026 was $-196.00M. For the 2026 fiscal year, MOH's free cash flow was decreased by $-37.00M and operating cash flow was $-159.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.69 | 1.62 | 1.54 | 1.47 | 1.43 |
| Quick Ratio | 1.69 | 1.62 | 1.54 | 1.47 | 1.43 |
| Cash Ratio | 0.58 | 0.59 | 0.59 | 0.58 | 0.63 |
| Solvency Ratio | 0.06 | 0.12 | 0.12 | 0.10 | 0.08 |
| Operating Cash Flow Ratio | -0.07 | 0.08 | 0.20 | 0.11 | 0.30 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 949.00M | $ 1.64B | $ 1.86B | $ 734.00M | $ 485.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.25 | 0.20 | 0.16 | 0.19 | 0.20 |
| Debt-to-Equity Ratio | 0.97 | 0.69 | 0.57 | 0.81 | 0.91 |
| Debt-to-Capital Ratio | 0.49 | 0.41 | 0.36 | 0.45 | 0.48 |
| Long-Term Debt-to-Capital Ratio | 0.48 | 0.39 | 0.34 | 0.42 | 0.45 |
| Financial Leverage Ratio | 3.83 | 3.48 | 3.53 | 4.15 | 4.64 |
| Debt Service Coverage Ratio | 4.47 | 12.57 | 12.58 | 9.80 | 7.58 |
| Interest Coverage Ratio | 4.07 | 14.47 | 14.43 | 10.66 | 8.50 |
| Debt to Market Cap | 0.43 | 0.17 | 0.10 | 0.11 | 0.12 |
| Interest Debt Per Share | 81.55 | 56.38 | 42.93 | 43.27 | 43.46 |
| Net Debt to EBITDA | -0.31 | -0.82 | -1.41 | -1.20 | -1.82 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.97% | 11.65% | 12.72% | 12.28% | 11.81% |
| EBIT Margin | 1.72% | 4.20% | 4.62% | 3.67% | 3.58% |
| EBITDA Margin | 2.15% | 4.66% | 5.12% | 4.22% | 4.05% |
| Operating Profit Margin | 1.72% | 4.20% | 4.62% | 3.67% | 3.67% |
| Pretax Profit Margin | 1.30% | 3.91% | 4.30% | 3.32% | 3.15% |
| Net Profit Margin | 1.04% | 2.90% | 3.20% | 2.48% | 2.37% |
| Continuous Operations Profit Margin | 1.04% | 2.90% | 3.20% | 2.48% | 2.37% |
| Net Income Per EBT | 80.14% | 74.20% | 74.52% | 74.51% | 75.31% |
| EBT Per EBIT | 75.42% | 93.09% | 93.07% | 90.62% | 85.78% |
| Return on Assets (ROA) | 3.03% | 7.54% | 7.33% | 6.43% | 5.40% |
| Return on Equity (ROE) | 11.60% | 26.22% | 25.88% | 26.72% | 25.06% |
| Return on Capital Employed (ROCE) | 9.53% | 22.07% | 23.39% | 21.49% | 19.76% |
| Return on Invested Capital (ROIC) | 7.64% | 16.38% | 17.43% | 16.01% | 14.88% |
| Return on Tangible Assets | 3.53% | 8.61% | 8.12% | 7.25% | 6.01% |
| Earnings Yield | 5.35% | 7.06% | 5.20% | 4.15% | 3.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.86 | 12.32 | 10.98 | 13.89 | 12.76 |
| Payables Turnover | 37.83 | 26.98 | 23.75 | 31.55 | 29.09 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 150.92 | 141.15 | 126.19 | 123.45 | 70.13 |
| Asset Turnover | 2.92 | 2.60 | 2.29 | 2.60 | 2.27 |
| Working Capital Turnover Ratio | 9.13 | 8.79 | 8.96 | 10.24 | 9.37 |
| Cash Conversion Cycle | 18.74 | 16.09 | 17.89 | 14.71 | 16.06 |
| Days of Sales Outstanding | 28.39 | 29.62 | 33.25 | 26.28 | 28.61 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 9.65 | 13.53 | 15.37 | 11.57 | 12.55 |
| Operating Cycle | 28.39 | 29.62 | 33.25 | 26.28 | 28.61 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -10.53 | 11.22 | 28.61 | 13.37 | 36.66 |
| Free Cash Flow Per Share | -12.52 | 9.48 | 27.16 | 11.80 | 35.33 |
| Dividend Paid and CapEx Coverage Ratio | -5.30 | 6.44 | 19.79 | 8.49 | 27.52 |
| Capital Expenditure Coverage Ratio | -5.30 | 6.44 | 19.79 | 8.49 | 27.52 |
| Operating Cash Flow Coverage Ratio | -0.14 | 0.21 | 0.70 | 0.32 | 0.89 |
| Operating Cash Flow to Sales Ratio | -0.01 | 0.02 | 0.05 | 0.02 | 0.08 |
| Free Cash Flow Yield | -7.22% | 3.26% | 7.52% | 3.57% | 11.11% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.43 | 14.18 | 19.24 | 24.10 | 27.90 |
| Price-to-Sales (P/S) Ratio | 0.19 | 0.41 | 0.62 | 0.60 | 0.66 |
| Price-to-Book (P/B) Ratio | 2.17 | 3.72 | 4.98 | 6.44 | 6.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.86 | 30.71 | 13.30 | 27.99 | 9.00 |
| Price-to-Operating Cash Flow Ratio | -16.48 | 25.94 | 12.63 | 24.69 | 8.68 |
| Price-to-Earnings Growth (PEG) Ratio | -0.34 | 1.47 | 0.53 | 1.19 | -318.32 |
| Enterprise Value Multiple | 8.73 | 8.01 | 10.62 | 12.95 | 14.51 |
| Enterprise Value | 8.52B | 15.16B | 18.53B | 17.47B | 16.34B |
| EV to EBITDA | 8.73 | 8.01 | 10.62 | 12.95 | 14.51 |
| EV to Sales | 0.19 | 0.37 | 0.54 | 0.55 | 0.59 |
| EV to Free Cash Flow | -13.39 | 27.87 | 11.74 | 25.62 | 8.00 |
| EV to Operating Cash Flow | -15.92 | 23.54 | 11.15 | 22.60 | 7.71 |
| Tangible Book Value Per Share | 36.89 | 44.56 | 47.61 | 27.23 | 23.84 |
| Shareholders’ Equity Per Share | 80.11 | 78.33 | 72.55 | 51.28 | 45.50 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.26 | 0.25 | 0.25 | 0.25 |
| Revenue Per Share | 894.32 | 708.19 | 586.44 | 553.18 | 480.47 |
| Net Income Per Share | 9.29 | 20.54 | 18.78 | 13.70 | 11.40 |
| Tax Burden | 0.80 | 0.74 | 0.75 | 0.75 | 0.75 |
| Interest Burden | 0.75 | 0.93 | 0.93 | 0.91 | 0.88 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.13 | 0.55 | 1.52 | 0.98 | 3.22 |
Currency in USD
